arrow
H

Helen Merkens

british columbia cancer agency
H指数:21
被引数:1,789

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthesis and Evaluation of Novel 68Ga-Labeled GRPR-Targeted PET Tracers Derived from [d-Phe6; Pro14]Bombesin(6–14) and [d-Phe6; des-Met14]Bombesin(6–14) Sequences

[d-Phe6; Pro14] 蛙皮素 (6-14) 和 [d-Phe6; des-Met14] 蛙皮素 (6-14) 序列衍生的新型68ga标记的GRPR靶向PET示踪剂的合成和评估

2026-01-280
PRE
Bifunctional sulfur-rich macrocyclic chelators and their immunoconjugates for the targeted delivery of theranostic mercury-197

双功能硫富集大环螯合剂及其免疫偶联物用于靶向递送诊疗用汞-197

2025-10-010
OAAI
Synthesis and evaluation of HOPO-O8-Methyl-tetrazine as a bifunctional chelator for use in [89Zr]Zr4+, [161Tb]Tb3+ and [227Th]Th4+ radioimmunoconjugates

HOPO-O8-甲基-四嗪的合成与评价:作为用于[89Zr]Zr4+、[161Tb]Tb3+和[227Th]Th4+放射免疫偶联物的双功能螯合剂

2025-09-150
OAAI
Synthesis and Preclinical Evaluation of Two Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeted Tracers with 2-Nal-Containing PSMA-Targeted Pharmacophore and Pyridine-Based FAP-Targeted Pharmacophore

两种新型68ga标记的双特异性PSMA/FAP靶向示踪剂的合成和临床前评估,所述示踪剂具有含2-nal-psma靶向药效团和基于吡啶的FAP靶向药效团

2024-02-092
OAAI
Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE-A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours

[155/161Tb]Tb-Crown-TATE的临床前评估-一种针对神经内分泌肿瘤的新型SPECT成像治疗剂

2023-04-0115
OAAI